Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
United States
UBMD Neurolgy, Buffalo, New York Age range
55 Years – 75 Years
Last updated November 2025